Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Lung Cancer, Colorectal Cancer, Ovarian Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Healthy Studies, Psychiatric, Women's Studies, Bladder Cancer |
| Therapuetic Areas: | Oncology, Psychiatry / Psychology, Other, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/13/2019 |
| Start Date: | October 2013 |
| End Date: | October 2023 |
A Randomized Trial of a Family Caregiver Palliative Care Intervention
This randomized clinical trial studies the Family Caregiver Palliative Care Intervention in
supporting caregivers of patients with stage II-IV gastrointestinal, gynecologic, urologic
and lung cancers. Education and telephone counseling may reduce stress and improve the
well-being and quality of life of caregivers of cancer patients.
supporting caregivers of patients with stage II-IV gastrointestinal, gynecologic, urologic
and lung cancers. Education and telephone counseling may reduce stress and improve the
well-being and quality of life of caregivers of cancer patients.
PRIMARY OBJECTIVES: I. Test the effects of the Family Caregiver Palliative Care Intervention
(FCPCI) on family caregivers of patients with gastrointestinal, gynecologic, urologic and
lung cancers in the experimental group on caregiver burden and caregiving skills preparedness
as compared to family caregivers in the control group.
II. Test the effects of the FCPCI on family caregivers of patients with gastrointestinal,
gynecologic, urologic and lung cancers in the experimental group on quality of life (QOL) and
psychological distress as compared to family caregivers in the control group.
SECONDARY OBJECTIVES: I. Describe family caregivers' self-care behavior, comparing the
experimental and control groups.
II. Describe family caregivers' resource use, comparing the experimental and control groups.
III. Identify subgroups of family caregivers who benefit most from the FCPCI in relation to
sociodemographic, health status, and patient characteristics.
IV. Describe family caregivers' satisfaction with the FCPCI.
V. Describe caregiver out-of-pocket costs and the cost of the intervention.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants receive FCPCI with an advanced practice nurse (APN), comprising 4 home
education sessions once weekly followed by 4 telephone support sessions for 30 minutes once
monthly and 24 hour telephone support available for 6 months.
ARM II: Participants receive usual care
(FCPCI) on family caregivers of patients with gastrointestinal, gynecologic, urologic and
lung cancers in the experimental group on caregiver burden and caregiving skills preparedness
as compared to family caregivers in the control group.
II. Test the effects of the FCPCI on family caregivers of patients with gastrointestinal,
gynecologic, urologic and lung cancers in the experimental group on quality of life (QOL) and
psychological distress as compared to family caregivers in the control group.
SECONDARY OBJECTIVES: I. Describe family caregivers' self-care behavior, comparing the
experimental and control groups.
II. Describe family caregivers' resource use, comparing the experimental and control groups.
III. Identify subgroups of family caregivers who benefit most from the FCPCI in relation to
sociodemographic, health status, and patient characteristics.
IV. Describe family caregivers' satisfaction with the FCPCI.
V. Describe caregiver out-of-pocket costs and the cost of the intervention.
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants receive FCPCI with an advanced practice nurse (APN), comprising 4 home
education sessions once weekly followed by 4 telephone support sessions for 30 minutes once
monthly and 24 hour telephone support available for 6 months.
ARM II: Participants receive usual care
Inclusion Criteria:
- Primary family caregivers of cancer patients with gastrointestinal (colorectal,
pancreatic, gastric), gynecologic, urinary or lung cancers who are entering the City
of Hope for treatment or follow-up
- Primary family caregivers of cancer patients who are diagnosed with stage II-IV
disease
- Primary family caregivers of cancer patients with > 6 months prognosis
- Living within a 50 mile radius of the City of Hope
We found this trial at
1
site
Duarte, California 91010
Principal Investigator: Betty Ferrell
Phone: 800-826-4673
Click here to add this to my saved trials
